Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,068
datasets available to search
ShareScore release 0.9.0
Dataset results
1,068 results for “PD-1”
TC Plus PD-1 Inhibitors Combined With Anlotinib for Advanced Advanced Esophageal Cancer
ClinicalTrials.gov study NCT04471480. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT04907370. IPD Sharing: NO. Countries: 1. Publications: 6.
Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma
ClinicalTrials.gov study NCT03964298. IPD Sharing: NO. Countries: 1. Publications: 1.
PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma
ClinicalTrials.gov study NCT05430698. IPD Sharing: NO. Countries: 1. Publications: 14.
A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor
ClinicalTrials.gov study NCT05374512. IPD Sharing: YES. Countries: 23. Publications: 1.
Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed
ClinicalTrials.gov study NCT06102759. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)
ClinicalTrials.gov study NCT06631326. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors
ClinicalTrials.gov study NCT02715284. IPD Sharing: YES. Countries: 10. Publications: 11.
Single-center, Prospective Cohort Study of PD-1 Inhibitors on Clinical Outcomes of Carotid Plaques in Tumor Patients
ClinicalTrials.gov study NCT05549336. IPD Sharing: UNDECIDED. Countries: 1. Publications: 5.
PD-1 Antibody and Lenvatinib Plus TACE on Downstaging BCLC B/C HCC
ClinicalTrials.gov study NCT04974281. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma
ClinicalTrials.gov study NCT06957938. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06342167. IPD Sharing: NO. Countries: 1. Publications: 10.
Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma
ClinicalTrials.gov study NCT04997837. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer
ClinicalTrials.gov study NCT05484024. IPD Sharing: NO. Countries: 1. Publications: 2.
Effectiveness of Neoadjuvant Chemotherapy Combined With PD-1 Monoclonal Antibody in the Treatment of Operable Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05174325. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Pilot Study Of Anti-Programmed Death Ligand-1 (Anti-PD-L1, Atezolizumab) In Asymptomatic Myeloma
ClinicalTrials.gov study NCT02784483. IPD Sharing: NO. Countries: 1. Publications: 1.
GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC
ClinicalTrials.gov study NCT06505486. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Deep learning to estimate durable clinical benefit and prognosis from patients with non-small cell lung cancer treated with PD-1/PD-L1 blockade
Open the record for dataset details and reuse information.
ESMO-GROW checklist for the publication PD-1/PD-L1 blockade plus abnobaViscum® therapy is associated with improved survival in advanced or metastasized NSCLC patients, a real-world data registry study according to the ESMO-GROW criteria
Open the record for dataset details and reuse information.
Vopratelimab (JTX-2011) Alone and in Combination With Anti-Programmed Cell Death Protein 1 (PD-1) or Anti-Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) in Subjects With Advanced and/or Refractory Solid Tu
ClinicalTrials.gov study NCT04319224. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.